Emilio Ros

Dr. Emilio Ros served as the creator and leader of the Lipid Unit, Endocrinology and Nutrition Service at Hospital Clínic, Barcelona until 2016. Currently, he holds the position of Emeritus Researcher at the Institut de Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona. Additionally, he is a former Principal Investigator and a current member of the CIBEROBN Group at Instituto de Salud Carlos III, Madrid.

During his postgraduate training from 1970 to 1976 in the United States (New York and Boston), Dr. Ros obtained the American Board of Internal Medicine and the American Board of Gastroenterology. He played a pivotal role as a founding member of the Spanish Society of Arteriosclerosis (SEA) and was the founder and editor of its official journal, Clínica e Investigación en Arteriosclerosis. He is an esteemed member of the European Atherosclerosis Society (EAS), International Atherosclerosis Society (IAS), American Society of Nutrition, and American College of Cardiology. From 2000 to 2005, he served as the president of the Ibero-Latin American Atherosclerosis Society (SILAT).

Dr. Emilio Ros’s outstanding contributions to the fields of nutrition, lipidology, and atherosclerosis have garnered global recognition, as he has been acknowledged as one of the top 1% most cited and influential scientists worldwide by Clarivate Analytics from 2018 to 2021. His extensive research portfolio includes 530 original articles, 95 reviews, and 30 editorials published in renowned journals. Additionally, he has contributed 90 book chapters, showcasing his breadth of knowledge and expertise. Notably, his Google Scholar index stands at 113, and he possesses an ORCID identifier (0000-0002-2573-1294). To honor his remarkable scientific career, Dr. Emilio Ros has received several prestigious awards, including the Best Scientific Career in Nutrition from the Danone Foundation in 2013, the SEA (Spanish Society of Arteriosclerosis) in 2014, and the Catalan Nutrition Centre in 2015. One of his notable accomplishments was leading the nutritional intervention in the groundbreaking clinical study PREDIMED, which focused on the Mediterranean diet for primary cardiovascular prevention.